Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

Stäubli Robotics and Quantum Surgical have launched a strategic partnership to create a centre of excellence in oncology robotics.

The alliance aims to strengthen the role of robotics in minimally invasive cancer treatments and to use the combined expertise of each company to create a world leader in patient care.

Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, that combines powerful software and a robotic platform to offer minimally invasive therapies in liver cancer.

Gerald Vogt, general manager Stäubli Robotics, says: “We are extremely grateful and proud that Quantum Surgical confirms their trust in Stäubli as a partner of choice for this new patient care application, at the service of human well-being.

“We are excited to contributing to Quantum’s vision together, with a long-term partner that stimulates us on a daily basis and makes us better.”

Bertin Nahum, president, and founder of Quantum Surgical, says: “We are honored to work with Stäubli, a company recognized for its technological excellence and savoir-faire, in order to share a vision of robotics and automation in healthcare.”